Literature DB >> 26062397

SecA: a potential antimicrobial target.

Arpana S Chaudhary1, Weixuan Chen1, Jinshan Jin2, Phang C Tai2, Binghe Wang1.   

Abstract

There is a consensus in the medical profession of the pressing need for novel antimicrobial agents due to issues related to drug resistance. In practice, solutions to this problem to a large degree lie with the identification of new and vital targets in bacteria and subsequently designing their inhibitors. We consider SecA a very promising antimicrobial target. In this review, we compile and analyze information available on SecA to show that inhibition of SecA has a multitude of consequences. Furthermore, we discuss issues critical to the design and evaluation of SecA inhibitors.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26062397      PMCID: PMC4479503          DOI: 10.4155/fmc.15.42

Source DB:  PubMed          Journal:  Future Med Chem        ISSN: 1756-8919            Impact factor:   3.808


  156 in total

1.  Structure of dimeric SecA, the Escherichia coli preprotein translocase motor.

Authors:  Yannis Papanikolau; Maria Papadovasilaki; Raimond B G Ravelli; Andrew A McCarthy; Stephen Cusack; Anastassios Economou; Kyriacos Petratos
Journal:  J Mol Biol       Date:  2006-12-23       Impact factor: 5.469

2.  Binding, activation and dissociation of the dimeric SecA ATPase at the dimeric SecYEG translocase.

Authors:  Franck Duong
Journal:  EMBO J       Date:  2003-09-01       Impact factor: 11.598

Review 3.  Traffic jam at the bacterial sec translocase: targeting the SecA nanomotor by small-molecule inhibitors.

Authors:  Kenneth Segers; Jozef Anné
Journal:  Chem Biol       Date:  2011-06-24

4.  A two-component multidrug efflux pump, EbrAB, in Bacillus subtilis.

Authors:  Y Masaoka; Y Ueno; Y Morita; T Kuroda; T Mizushima; T Tsuchiya
Journal:  J Bacteriol       Date:  2000-04       Impact factor: 3.490

5.  A novel dimer interface and conformational changes revealed by an X-ray structure of B. subtilis SecA.

Authors:  Jochen Zimmer; Weikai Li; Tom A Rapoport
Journal:  J Mol Biol       Date:  2006-08-22       Impact factor: 5.469

6.  Platensimycin is a selective FabF inhibitor with potent antibiotic properties.

Authors:  Jun Wang; Stephen M Soisson; Katherine Young; Wesley Shoop; Srinivas Kodali; Andrew Galgoci; Ronald Painter; Gopalakrishnan Parthasarathy; Yui S Tang; Richard Cummings; Sookhee Ha; Karen Dorso; Mary Motyl; Hiranthi Jayasuriya; John Ondeyka; Kithsiri Herath; Chaowei Zhang; Lorraine Hernandez; John Allocco; Angela Basilio; José R Tormo; Olga Genilloud; Francisca Vicente; Fernando Pelaez; Lawrence Colwell; Sang Ho Lee; Bruce Michael; Thomas Felcetto; Charles Gill; Lynn L Silver; Jeffery D Hermes; Ken Bartizal; John Barrett; Dennis Schmatz; Joseph W Becker; Doris Cully; Sheo B Singh
Journal:  Nature       Date:  2006-05-18       Impact factor: 49.962

7.  ATP is essential for protein translocation into Escherichia coli membrane vesicles.

Authors:  L Chen; P C Tai
Journal:  Proc Natl Acad Sci U S A       Date:  1985-07       Impact factor: 11.205

8.  Genes in the accessory sec locus of Streptococcus gordonii have three functionally distinct effects on the expression of the platelet-binding protein GspB.

Authors:  Daisuke Takamatsu; Barbara A Bensing; Paul M Sullam
Journal:  Mol Microbiol       Date:  2004-04       Impact factor: 3.501

Review 9.  Selective transport by SecA2: an expanding family of customized motor proteins.

Authors:  Barbara A Bensing; Ravin Seepersaud; Yihfen T Yen; Paul M Sullam
Journal:  Biochim Biophys Acta       Date:  2013-10-31

10.  Conformational flexibility and peptide interaction of the translocation ATPase SecA.

Authors:  Jochen Zimmer; Tom A Rapoport
Journal:  J Mol Biol       Date:  2009-10-20       Impact factor: 5.469

View more
  7 in total

Review 1.  SecA inhibitors as potential antimicrobial agents: differential actions on SecA-only and SecA-SecYEG protein-conducting channels.

Authors:  Jinshan Jin; Ying-Hsin Hsieh; Arpana S Chaudhary; Jianmei Cui; John E Houghton; Sen-Fang Sui; Binghe Wang; Phang C Tai
Journal:  FEMS Microbiol Lett       Date:  2018-08-01       Impact factor: 2.742

2.  Evaluation of small molecule SecA inhibitors against methicillin-resistant Staphylococcus aureus.

Authors:  Jinshan Jin; Jianmei Cui; Arpana Sagwal Chaudhary; Ying-Hsin Hsieh; Krishna Damera; Hao Zhang; Hsiuchin Yang; Binghe Wang; Phang C Tai
Journal:  Bioorg Med Chem       Date:  2015-09-21       Impact factor: 3.641

3.  Using Chemical Probes to Assess the Feasibility of Targeting SecA for Developing Antimicrobial Agents against Gram-Negative Bacteria.

Authors:  Jinshan Jin; Ying-Hsin Hsieh; Jianmei Cui; Krishna Damera; Chaofeng Dai; Arpana S Chaudhary; Hao Zhang; Hsiuchin Yang; Nannan Cao; Chun Jiang; Martti Vaara; Binghe Wang; Phang C Tai
Journal:  ChemMedChem       Date:  2016-10-18       Impact factor: 3.466

4.  Design, Synthesis and Evaluation of Triazole-Pyrimidine Analogues as SecA Inhibitors.

Authors:  Jianmei Cui; Jinshan Jin; Arpana Sagwal Chaudhary; Ying-hsin Hsieh; Hao Zhang; Chaofeng Dai; Krishna Damera; Weixuan Chen; Phang C Tai; Binghe Wang
Journal:  ChemMedChem       Date:  2015-11-26       Impact factor: 3.466

5.  Mutational Evolution of Pseudomonas aeruginosa Resistance to Ribosome-Targeting Antibiotics.

Authors:  Fernando Sanz-García; Sara Hernando-Amado; José L Martínez
Journal:  Front Genet       Date:  2018-10-18       Impact factor: 4.599

6.  Exploration of Survival Traits, Probiotic Determinants, Host Interactions, and Functional Evolution of Bifidobacterial Genomes Using Comparative Genomics.

Authors:  Vikas Sharma; Fauzul Mobeen; Tulika Prakash
Journal:  Genes (Basel)       Date:  2018-10-01       Impact factor: 4.096

Review 7.  Pore-Forming Toxins During Bacterial Infection: Molecular Mechanisms and Potential Therapeutic Targets.

Authors:  Haijie Hu; Min Liu; Shuang Sun
Journal:  Drug Des Devel Ther       Date:  2021-09-07       Impact factor: 4.162

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.